<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tian Y</submitter><funding>National Natural Science Foundation of China</funding><pagination>57</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11806715</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Liver transplantation is the most effective treatment for end-stage liver disease. However, the shortage of donor livers has become a significant obstacle to the advancement of liver transplantation. Mesenchymal stem cells-derived exosomes (MSCs-Exo) have been extensively investigated in liver diseases. However, the underlying mechanisms of how they can protect organ donation after cardiac death (DCD) livers remain unclear.&lt;h4>Methods&lt;/h4>In this study, an arterialized mouse non-heart-beating (NHB) liver transplantation model was used to investigate the effect of MSCs-Exo on NHB liver transplantation. The survival rates, histology, pro-inflammatory cytokine and chemokine expression, and underlying mechanisms were investigated.&lt;h4>Results&lt;/h4>The infusion of MSCs-Exo redu</pubmed_abstract><journal>Stem cell research &amp; therapy</journal><pubmed_title>Mesenchymal stem cells-derived exosomes attenuate mouse non-heart-beating liver transplantation through Mir-17-5p-regulated Kupffer cell pyroptosis.</pubmed_title><pmcid>PMC11806715</pmcid><funding_grant_id>No. 82000619</funding_grant_id><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Ye N</pubmed_authors><pubmed_authors>Tian Y</pubmed_authors><pubmed_authors>Jin M</pubmed_authors><pubmed_authors>Gao Z</pubmed_authors><pubmed_authors>Yan S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mesenchymal stem cells-derived exosomes attenuate mouse non-heart-beating liver transplantation through Mir-17-5p-regulated Kupffer cell pyroptosis.</name><description>&lt;h4>Background&lt;/h4>Liver transplantation is the most effective treatment for end-stage liver disease. However, the shortage of donor livers has become a significant obstacle to the advancement of liver transplantation. Mesenchymal stem cells-derived exosomes (MSCs-Exo) have been extensively investigated in liver diseases. However, the underlying mechanisms of how they can protect organ donation after cardiac death (DCD) livers remain unclear.&lt;h4>Methods&lt;/h4>In this study, an arterialized mouse non-heart-beating (NHB) liver transplantation model was used to investigate the effect of MSCs-Exo on NHB liver transplantation. The survival rates, histology, pro-inflammatory cytokine and chemokine expression, and underlying mechanisms were investigated.&lt;h4>Results&lt;/h4>The infusion of MSCs-Exo redu</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2025-04-05T09:41:00.055Z</modification><creation>2025-04-05T09:41:00.055Z</creation></dates><accession>S-EPMC11806715</accession><cross_references><pubmed>39920844</pubmed><doi>10.1186/s13287-025-04169-w</doi></cross_references></HashMap>